Cannabinoids: Mechanisms and therapeutic applications in the CNS

Current Medicinal Chemistry

Volumn 10, Issue 24, 2003, Pages 2719-2732

  Drysdale, Alison J ^a   Platt, Bettina ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Analgesia; Cannabinoids; Ischaemia; Multiple sclerosis; Neurodegeneration; Neuroprotection; Schizophrenia; Therapy

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (1,1 DIMETHYLHEPTYL) 2 (3 HYDROXY 7 HYDROXYMETHYLDECAHYDRO 1 NAPHTHYL)PHENOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; BAY 387271; CANNABIDIOL; CANNABIGEROL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CANNABINOL; CANNABIS; CODEINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEXANABINOL; DRONABINOL; GLUCOSE; GLUTAMIC ACID; LEVONANTRADOL; METHANANDAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NABILONE; OLIVETOL; PALMIDROL; PSYCHOTROPIC AGENT; RIMONABANT; SR 141716 A; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URB 532;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DISEASE MODEL; DRUG DEPENDENCE; DRUG MECHANISM; DRUG POTENCY; EPILEPSY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; MEMORY DISORDER; MULTIPLE SCLEROSIS; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; REVIEW; SCHIZOPHRENIA; STROKE;

ANIMALS; BRAIN; BRAIN DISEASES; CANNABINOIDS; HUMANS; NEUROPROTECTIVE AGENTS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 0345255894     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033456387     Document Type: Review

References (187)

1. Maldonado, R.; Rodriguez De Fonseca, F. Journal of Neuroscience, 2002, 22, 3326.
2. Varvel, S.A.; Lichtman, A.H. Journal of Pharmacology & Experimental Therapeutics, 2002, 301, 915.
3. Davies, S.N.; Pertwee, R.G.; Riedel, G. Neuropharmacology, 2002, 42, 993.
4. Robinson, L.; Platt, B.; Riedel, G. In Memories are made of these: from messengers to molecules; Riedel, G.; Platt, B. Eds. Landes Bioscience: Austin TX, USA, 2003 (in press).
5. Rey, J.M.; Tennant, C.C. British Medical Journal, 2002, 325, 1183.
6. Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Science, 1992, 258, 1946.
7. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R. Biochemical Pharmacology, 1995, 50, 83.
8. Fride, E.; Barg, J.; Levy, R.; Saya, D.; Heldman, E.; Mechoulam, R.; Vogel, Z. Journal of Pharmacology & Experimental Therapeutics, 1995, 272, 699.
9. Devane, W.A.; Breuer, A.; Sheskin, T.; Jarbe, T.U.; Eisen, M.S.; Mechoulam, R. Journal of Medicinal Chemistry, 1992, 35, 2065.
10. Howlett, A.C.; Champion, T.M.; Wilken, G.H.; Mechoulam, R. Neuropharmacology, 1990, 29, 161.
11. Eshhar, N., Striem, S.; Biegon, A. Neuroreport, 1993, 5, 237.
12. Pertwee, R.G.; Ross, R.A. Prostaglandins Leukotrienes & Essential Fatty Acids, 2001, 66, 101.
13. Pop, E. Current Opinion in Chemical Biology, 1999, 3, 418.
14. Porter, A.C.; Felder, C.C. Pharmacology & Therapeutics, 2001, 90, 45.
15. Di Marzo, V.; Melck, D.; Bisogno, T.; De Petrocellis, L. Trends in Neurosciences, 1998, 21, 521,
16. Piomelli, D.; Beltramo, M.; Giuffrida, A.; Stella, N. Neurobiology of Disease, 1998, 5, 462
17. Bisogno, T.; Berrendero, F.; Ambrosino, G.; Cebeira, M.; Ramos, J.A.; Fernandez-Ruiz, J.J.; Di Marzo, V. Biochemical & Biophysical Research Communications, 1999, 256, 377.
18. Wilson, R.I.; Nicoll, R.A. Nature, 2001, 410, 588.
19. Maejima, T.; Hashimoto, K.; Yoshida, T.; Aiba, A.; Kano, M. Neuron, 2001, 31, 463.
20. Elphick, M.R.; Egertova, M. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences, 2001, 356, 381.
21. Schlicker, E.; Kathmann, M. Trends in Pharmacological Sciences, 2001, 22, 565.
22. Di Marzo, V.; Fontana, A.; Cadas, H.; Schinelli, S.; Cimino, G.; Schwartz, J.C.; Piomelli, D. Nature, 1994, 372, 686.
23. Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Nature, 1990, 346, 561.
24. Devane, W.A.; Dysarz, F.A.; Johnson, M.R.; Melvin, L.S.; Howlett, A.C. Molecular Pharmacology, 1988, 34, 605.
25. Munro, S.; Thomas, K.L.; Abu-Shaar, M. Nature, 1993, 365, 61.
26. Herkenham, M.; Lynn, A.B.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; De Costa, B.R.; Rice, K.C. Proceedings of the National Academy of Sciences of the United States of America, 1990, 87, 1932.
27. Pertwee, R.G. Progress in Neurobiology, 2001, 63, 569.
28. Griffin, G.; Tao, Q.; Abood, M.E. Journal of Pharmacology & Experimental Therapeutics, 2000, 292, 886.
29. Zygmunt, P.M.; Andersson, D.A.; Hogestatt, E.D. Journal of Neuroscience, 2002, 22, 4720.
30. Wilson, R.J.; Nicoll, R.A. Science, 2002, 296, 678.
31. Breivogel, C.S.; Griffin, G.; Di Marzo, V. & Martin, B.R. Molecular Pharmacology, 2001, 60, 155.
32. Marsicano, G.; Moosmann, B.; Hermann, H.; Lutz, B.; Behl, C. Journal of Neurochemistry, 2002, 80, 448.
33. Jarai, Z.; Wagner, J.A.; Varga, K.; Lake, K.D.; Compton, D.R.; Martin, B.R.; Zimmer, A.M.; Bonner, T.I.; Buckley, N.E.; Mezey, E.; Razdan, R.K.; Zimmer, A.; Kunos, G. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96, 14136.
34. Wagner, J.A.; Varga, K.; Jarai, Z.; Kunos, G. Hypertension, 1999, 33, 429.
35. Venance, L.; Piomelli, D.; Glowinski, J.; Giaume, C. Nature, 1995, 376, 590.
36. Ross, R.A.; Gibson, T.M.; Brockie, H.C.; Leslie, M.; Pashmi, G.; Craib, S.J.; Di Marzo, V.; Pertwee, R.G. British Journal of Pharmacology, 2001, 132, 631.
37. Smart, D.; Gunthorpe, M.J.; Jerman, J.C.; Nasir, S.; Gray, J.; Muir, A.I.; Chambers, J.K.; Randall, A.D.; Davis, J.B. British Journal of Pharmacology, 2000, 129, 227.
38. Zygmunt, P.M.; Petersson, J.; Andersson, D.A.; Chuang, H.; Sorgard, M.; Di Marzo, V.; Julius, D.; Hogestatt, E.D. Nature, 1999, 400, 452.
39. Calignano, A.; La Rana, G.; Giuffrida, A.; Piomelli, D. Nature, 1998, 394, 277.
40. Howlett, A.C.; Qualy, J.M.; Khachatrian, L.L. Molecular Pharmacology, 1986, 29, 307.
41. Howlett, A.C.; Fleming, R.M. Molecular Pharmacology, 1984, 26, 532.
42. Ameri, A. Progress in Neurobiology, 1999, 58, 315.
43. Weisskopf, M.G.; Castillo, P.E.; Zalutsky, R.A.; Nicoll, R.A. Science, 1994, 265, 1878.
44. Frey, U.; Huang, Y.Y.; Kandel, E.R. Science, 1993, 260, 1661.
45. Selcher, J.C.; Weeber, E.J.; Sweatt, J.D. In Memories are made of these: from messengers to molecules; Riedel, G.; Platt, B. Eds.; Landes Bioscience: Austin TX, USA, 2003 (in press).
46. Chan, G.C.; Hinds, T.R.; Impey, S.; Storm, D.R. Journal of Neuroscience, 1998, 18, 5322.
47. Guzman, M.; Galve-Roperh, I.; Sanchez, C. Trends in Pharmacological Sciences, 2001, 22, 19.
48. Sullivan, J.M. Journal of Neurophysiology, 1999, 82, 1286.
49. Nakazi, M.; Bauer, U.; Nickel, T.; Kathmann, M.; Schlicker, E. Naunyn-Schmiedebergs Archives of Pharmacology, 2000, 361, 19.
50. Kathmann, M.; Bauer, U.; Schlicker, E.; Gothert, M. Naunyn-Schmiedebergs Archives of Pharmacology, 1999, 359, 466.
51. Szabo, B.; Muller, T.; Koch, H. Journal of Neurochemistry, 1999, 73, 1084.
52. Shen, M.; Piser, T.M.; Seybold, V.S.; Thayer, S.A. Journal of Neuroscience, 1996, 16, 4322.
53. Ishac, E.J.; Jiang, L.; Lake, K.D.; Varga, K.; Abood, M.E.; Kunos, G. British Journal of Pharmacology, 1996, 118, 2023.
54. Robbe, D.; Kopf, M.; Remaury, A.; Bockaert, J.; Manzoni, O.J. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99, 8384.
55. Horn, J.; Limburg, M. Stroke, 2001, 32, 570.
56. Davis, S.M.; Lees, K.R.; Albers, G.W.; Diener, H.C.; Markabi, S.; Karlsson, G.; Norris, J. Stroke, 2000, 31, 347.
57. Skaper, S.D.; Buriani, A.; Dal Toso, R.; Petrelli, L.; Romanello, S.; Facci, L.; Leon, A. Proceedings of the National Academy of Sciences of the United States of America, 1996, 93, 3984.
58. Caulfield, M.P.; Brown, D.A. British Journal of Pharmacology, 1992, 106, 231.
59. Mackie, K.; Hille, B. Proceedings of the National Academy of Sciences of the United States of America, 1992, 89, 3825.
60. Robbe, D.; Alonso, G.; Duchamp, F.; Bockaert, J.; Manzoni, O.J. Journal of Neuroscience, 2001, 21, 109.
61. Hampson, R.E.; Mu, J.; Deadwyler, S.A. Journal of Physiology, 2000, 84, 2356.
62. Eshhar, N.; Striem, S.; Kohen, R.; Tirosh, O.; Biegon, A. European Journal of Pharmacology, 1995, 283, 19.
63. Nadler, V.; Biegon, A.; Beit-Yannai, E.; Adamchik, J.; Shohami, E. Brain Research, 1995, 685, 1.
64. Shohami, E.; Gallily, R.; Mechoulam, R.; Bass, R.; Ben-Hur, T. Journal of Neuroimmunology, 1997, 72, 169.
65. Shohami, E.; Novikov, M.; Mechoulam, R. Journal of Neurotrauma, 1993, 10, 109.
66. Carlisle, S.J.; Marciano-Cabral, F.; Staab, A.; Ludwick, C.; Cabral, G.A. International Immunopharmacology, 2002, 2, 69.
67. Arévalo-Martin, A.; Vela, J.M.; Molina-Holgado, E.; Borrell, J.; Guaza, C. Journal of Neuroscience, 2003, 23, 2511.
68. Gallily, R.; Yamin, A.; Waksmann, Y.; Ovadia, H.; Weidenfeld, J.; Bar-Joseph, A.; Biegon, A.;. Mechoulam, R.; Shohami, E. Journal of Pharmacology & Experimental Therapeutics, 1997, 283, 918.
69. Little, P.J.; Compton, D.R.; Mechoulam, R.; Martin, B.R. Pharmacology, Biochemistry & Behavior, 1989, 32, 661.
70. Mechoulam, R.; Feigenbaum, J.J.; Lander, N.; Segal, M.; Jarbe, T.U.; Hiltunen, A.J.; Consroe, P. Experientia, 1988, 44, 762.
71. Nagayama, T.; Sinor, A.D.; Simon, R.P.; Chen, J.; Graham, S.H.; Jin, K:L.; Greenberg, D.A. Journal of Neuroscience, 1999, 19, 2987.
72. Van Der Stelt, M.; Veldhuis, W.B.; Bar, P.R.; Veldink, G.A.; Vliegenthart, J.F.; Nicolay, K. Journal of Neuroscience, 2001, 21, 6475.
73. Hampson, A.J.; Grimaldi, M.; Axelrod, J.; Wink D. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95, 8268.
74. Ben-Ari, Y. Neuroscience, 1985, 14, 375.
75. Nadler, J.V. Life Sciences, 1981, 29, 2031.
76. Akinshola, B.E.; Chakrabarti, A.; Onaivi, E.S. Neurochemical Research, 1999, 24, 1233.
77. Abood, M.E.; Rizvi, G.; Sallapudi, N.; McAllister, S.D. Neuroscience Letters, 2001, 309, 197.
78. Consroe, P.; Benedito, M.A.; Leite, J.R.; Carlini, E.A.; Mechoulam, R. European Journal of Pharmacology, 1982, 83, 293.
79. Consroe, P.; Martin, A.; Singh, V. Journal of Clinical Pharmacology, 1981, 21, 428S.
80. Karler, R.; Turkanis, S.A. Journal of Clinical Pharmacology, 1981, 21, 437S.
81. Cunha, J.M.; Carlini, E.A.; Pereira, A.E.; Ramos, O.L.; Pimentel, C.; Gagliardi, R.; Sanvito, W.L.; Lander, N.; Mechoulam, R. Pharmacology, 1980, 21, 175.
82. Sanudo-Pena, M.C.; Fride, E. In Biology of Marijuana: From Gene to Behavior; Onaivi, Ed.; Taylor & Francis: London, 2002; pp. 205-233.
83. Sanudo-Pena, M.C.; Tsou, K.; Romero, J.; Mackie, K.; Walker, J.M. Brain Research, 2000, 853, 207.
84. Herkenham, M.; Lynn, A.B.; Johnson, M.R.; Melvin, L.S.; De Costa, B.R.; Rice, K.C. Journal of Neuroscience, 1991, 11, 563.
85. Striem, S.; Bar-Joseph, A.; Berkovitch, Y.; Biegon, A. European Journal of Pharmacology, 1997, 338, 205.
86. Pharmos Corporation, 2002, http://www.pharmoscorp.com/development/dexanabinol.html
87. Piomelli, D.; Giuffrida, A.; Calignano, A.; Rodriguez De Fonseca, F. Trends in Pharmacological Sciences, 2000, 21, 218.
88. Tanda, G.; Pontieri, F.E.; Di Chiara, G. Science, 1997, 276, 2048.
89. Sieradzan, K.A.; Fox, S.H.; Hill, M.; Dick, J.P.; Crossman, A.R.; Brotchie, J.M. Neurology, 2001, 57, 2108.
90. Fox, S.H.; Henry, B.; Hill, M.; Crossman, A.; Brotchie, J. Movement Disorders, 2002, 17, 1180.
91. Glass, M.; Dragunow, M.; Faull, R.L. Neuroscience, 2000, 97, 505.
92. Richfield, E.K.; Herkenham, M. Annals of Neurology, 1994, 36, 577.
93. Consroe, P.; Laguna, J.; Allender, J.; Snider, S.; Stern, L.; Sandyk, R.; Kennedy, K.; Schram, K. Pharmacology, Biochemistry & Behavior, 1991, 40, 701.
94. Peyser, C.E.; Folstein, M.; Chase, G.A.; Starkstein, S.; Brandt, J.; Cockrell, J.R.; Bylsma, F.; Coyle, J.T.; McHugh, P.R.; Folstein, S.E. American Journal of Psychiatry, 1995, 152, 1771.
95. Sinor, A.D.; Irvin, S.M.; Greenberg, D.A. Neuroscience Letters, 2000, 278, 157.
96. Pertwee, R.G. Pharmacology and Therapeutics, 2002, 95, 165.
97. Mechoulam, R.; Ben-Shabat, S. Natural Product Reports, 1999, 16, 131.
98. Martyn, C.N.; Illis, L.S.; Thom, J. Lancet, 1995, 345, 579.
99. Clifford, D.B. Annals of Neurology, 1983, 13, 669.
100. Consroe, P.; Musty, R.; Rein, J.; Tillery, W.; Pertwee, R. European Neurology, 1997, 38, 44.
101. Brenneisen, R.; Egli, A.; Elsohly, M.A.; Henn, V.; Spiess, Y. International Journal of Clinical Pharmacology & Therapeutics, 1996, 34, 446.
102. Ungerleider, J.T.; Andyrsiak, T.; Fairbanks, L.; Ellison, G.W.; Myers, L.W. Advances in Alcohol & Substance Abuse, 1987, 7, 39.
103. Turski, L.; Klockgether, T.; Schwarz M.; Turski, W.A.; Sontag, K.H. Annals of Neurology, 1990, 28, 341.
104. Singer, H.S. Current Neurology & Neuroscience Reports, 2001, 1, 195.
105. Muller-Vahl, K.R.; Schneider, U.; Kolbe, H.; Emrich, H.M. American Journal of Psychiatry, 1999, 156, 495.
106. Formukong, E.A.; Evans, A.T.; Evans, F.J. Journal of Pharmacy & Pharmacology, 1988, 40, 132.
107. Richter, A.; Loscher, W. European Journal of Pharmacology, 1994, 264, 371.
108. Consroe, P.; Musty, R.; Conti, L.H., 1988. Cited in Musty, R.E. Biology of Marijuana: From Gene to Behavior; Onaivi, Ed.; Taylor & Francis: London, 2002, pp. 45-74.
109. Achiron, A.; Miron, S.; Lavie, V.; Margalit, R.; Biegon, A. Journal of Neuroimmunology, 2000, 102, 26.
110. Baker, D.; Pryce, G.; Croxford, J.L.; Brown, P.; Pertwee, R.G.; Huffman, J.W.; Layward, L. Nature, 2000, 404, 84.
111. Lyman, W.D.; Sonett, J.R.; Brosnan, C.F.; Elkin, R.; Bornstein, M.B. Journal of Neuroimmunology, 1989, 23, 73.
112. Wirguin, I.; Mechoulam, R.; Breuer, A.; Schezen, E.; Weidenfeld, J.; Brenner, T. Immunopharmacology, 1994, 28, 209.
113. Molina-Holgado, F.; Molina-Holgado, E.; Guaza, C.; Rothwell, N.J. Journal of Neuroscience Research, 2002, 67, 829.
114. Bisogno, T.; De Petrocellis, L.; Di Marzo, V. Current Pharmaceutical Design, 2002, 8, 533.
115. Cravatt, B.F.; Demarest, K.; Patricelli, M.P.; Bracey, M.H.; Giang, D.K.; Martin, B.R.; Lichtman, A.H. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98, 9371.
116. Williamson, E.M.; Evans, F.J. Drugs, 2000, 60, 1303.
117. Welch, S.P.; Stevens, D.L. Journal of Pharmacology & Experimental Therapeutics, 1992, 262, 10.
118. Noyes, R.; Brunk, S.F.; Avery, D.H.; Canter, A. Clinical Pharmacology and Therapeutics, 1975, 18, 84.
119. Notcutt, W.G.; Price, M; Chapman, G. Pharmaceutical Sciences, 1997, 3, 11.
120. Mikuriya, T.H., 1999. Cited in Musty, R.E. Biology of Marijuana: From Gene to Behavior; Onaivi, Ed.; Taylor & Francis: London, 2002, pp. 45-74.
121. Consroe, P.; Tillery, W.; Rein, J.; Musty, R.E., 1998. Cited in Musty, R.E. Biology of Marijuana: From Gene to Behavior; Onaivi, Ed.; Taylor & Francis: London, 2002, pp. 45-74.
122. Vaughan, C.W.; Connor, M.; Bagley, E.E.; Christie, M.J. Molecular Pharmacology, 2000, 57, 288.
123. Vaughan, C.W.; McGregor, I.S.; Christie, M.J. British Journal of Pharmacology, 1999, 127, 935.
124. Mao, J.; Price, D.D.; Lu, J.; Keniston, L.; Mayer, D.J. Neuroscience Letters, 2000, 280, 13.
125. Chichewizc, D.L.; Welch S. 1999. Cited in Musty, R.E. Biology of Marijuana: From Gene to Behavior; Onaivi, Ed.; Taylor & Francis: London, 2002, pp. 45-74.
126. Plasse, T.F.; Gorter, R.W.; Krasnow, S.H.; Lane, M.; Shepard, K.V.; Wadleigh, R.G. Pharmacology, Biochemistry & Behavior, 1991, 40, 695.
127. Cabral, G.A.; Dove Pettit, D.A. Journal of Neuroimmunology, 1998, 83, 116.
128. Klein, T.W.; Newton, C.; Friedman, H. Immunology Today, 1998, 19, 373.
129. Van Sickle, M.D.; Oland, L.D.; Ho, W.; Hillard, C.J.; Mackie, K.; Davison, J.S.; Sharkey, K.A. Gastroenterology, 2001, 121, 767.
130. Inui, A. Pharmacological Reviews, 2000, 52, 35.
131. Inui A. Trends in Neurosciences, 1999, 22, 62.
132. Abrahamov, A.; Abrahamov, A.; Mechoulam, R. Life Sciences, 1995, 56, 2097.
133. Jain, A.K.; Ryan, J.R.; McMahon, F.G.; Smith, G. Journal of Clinical Pharmacology, 1981, 21, 320S.
134. Tyson, L.B.; Gralla, R.J.; Clark, R.A.; Kris, M.G.; Bordin, L.A.; Bosl, G.J. American Journal of Clinical Oncology. 1985, 8, 528.
135. Galve-Roperh, I.; Sanchez, C.; Cortes, M.L.; Del Pulgar, T.G.; Izquierdo, M.; Guzman, M. Nature Medicine, 2000, 6, 313.
136. Colasanti, B.K.; Brown, R.E.; Craig, C.R. General Pharmacology, 1984, 15, 479.
137. Colasanti, B.K. Journal of Ocular Pharmacology, 1990, 6, 259.
138. El-Mallakh, R.S. Headache, 1987, 27, 442.
139. Schnelle, M.; Grotenhermen, F.; Reif, M.; Gorter, R.W. Forschende Komplementarmedizin, 1999, 6, 28S.
140. Kathuria, S.; Gaetani, S.; Fegley, D.; Valiño, F.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; Rana, G.L.; Calignano, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V; Piomelli, D. Nature Medicine, 2003 (in press).
141. BBC News, 2002, http://news.bbc.co.uk/1/hi/england/2326833.stm
142. G W Pharmaceuticals, 2002, http://www.gwpharm.com/rese_clin_index.html
143. Royal Pharmaceutical Society of Great Britain, 2002, http://www.rpsgb.org.uk/
144. Mechoulam, R.; Panikashvili, D.; Shohami, E. Trends in Molecular Medicine, 2002, 8, 58.
145. Panikashvili, D.; Simeonidou, C.; Ben-Shabat, S.; Hanus, L.; Breuer, A.; Mechoulam, R.; Shohami, E. Nature, 2001, 413, 527.
146. Campbell, V.A. Neuropharmacology, 2001, 40, 702.
147. Hampson, A.J.; Grimaldi, M. European Journal of Neuroscience, 2001, 13, 1529.
148. Hillard, C.J. Journal of Pharmacology & Experimental Therapeutics, 2000, 294, 27.
149. Rawls, S.M.; Cowan, A.; Tallarida, R.J.; Geller, E.B.; Adler, M.W. Journal of Pharmacology & Experimental Therapeutics, 2002, 303, 395.
150. Fedorova, I; Hashimoto, A.; Fecik, R.A.; Hedrick, M.P.; Hanus, L.O.; Boger, D.L.; Rice, K.C.; Basile, A.S. Journal of Pharmacology & Experimental Therapeutics. 2001, 299, 332.
151. Rosenthal, M.S.; Kleber, H.D. Proceedings of the Association of American Physicians, 1999, 111, 159.
152. Rey, J.M.; Sawyer, M.G.; Raphael, B.; Patton, G.C.; Lynskey, M. British Journal of Psychiatry, 2002, 180, 216.
153. Bovasso, G.B. American Journal of Psychiatry, 2001, 158, 2033.
154. Hall, W.; Degenhardt, L. Australian & New Zealand Journal of Psychiatry, 2000, 34, 26.
155. McKay, D.R.; Tennant, C.C. Medical Journal of Australia, 2000, 172, 284.
156. Andreasson, S.; Allebeck, P.; Engstrom, A.; Rydberg, U. Lancet, 1987, 2, 1483.
157. Zammit, S.; Allebeck, P.; Andreasson; S.; Lundberg; I.; Lewis, G. British Medical Journal, 2002, 325, 1199.
158. Calhoun, S.R.; Galloway, G.P.; Smith, D.E. Journal of Psychoactive Drugs, 1998, 30, 187.
159. Joy, J.E.; Watson, S.J; Benson, J.A. Marijuana and Medicine: Assessing the Science Base, The National Academies Press: Washington, 1999.
160. Hanus, L.; Abu-Lafi, S.; Fride, E.; Breuer, A.; Vogel, Z.; Shalev, D.E.; Kustanovich, I.; Mechoulam, R. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98, 3662.
161. Pertwee, R.G. Expert Opinion on Investigational Drugs, 2000, 9, 1553.
162. Sugiura, T.; Kondo, S.; Kishimoto, S.; Miyashita, T.; Nakane, S.; Kodaka, T.; Suhara, Y.; Takayama, H.; Waku, K. Journal of Biological Chemistry, 2000, 275, 605.
163. Maccarrone, M.; Lorenzon, T.; Bari, M.; Melino, G.; Finazzi-Agro, A. Journal of Biological Chemistry, 2000, 275, 31938.
164. Downer, E.; Boland, B.; Fogarty, M.; Campbell, V. Neuroreport, 2001, 12, 3973.
165. Shen, M.; Thayer, S.A. Molecular Pharmacology, 1998, 54, 459.
166. Ferraro, L.; Tomasini, M.C.; Cassano, T.; Bebe, B.W.; Siniscalchi, A.; O'Connor, W.T.; Magee, P.; Tanganelli, S.; Cuomo V.; Antonelli, T. Journal of Neuroscience Research, 2001, 66, 298.
167. Mauler, F.; Mittendorf, J.; Horvath, E.; De Vry, J. Journal of Pharmacology & Experimental Therapeutics, 2002, 302, 359.
168. Louw, D.F.; Yang, F.W.; Sutherland, G.R. Brain Research, 2000, 857, 183.
169. Vered, M.; Bar-Joseph, A.; Belayev, L.; Berkovich, Y.; Biegon, A. Acta Neurochirurgica, 1994, 60, 335S.
170. Bar-Joseph, A.; Berkovitch, Y.; Adamchik, J.; Biegon, A. Molecular & Chemical Neuropathology, 1994, 23, 125.
171. Belayev, L.; Bar-Joseph, A.; Adamchik, J.; Biegon, A. Molecular & Chemical Neuropathology, 1995, 25, 19.
172. Belayev, L.; Busto, R.; Zhao, W.; Ginsberg, M.D. Stroke, 1995, 26, 2313.
173. Belayev, L.; Busto, R.; Watson, B.D.; Ginsberg, M.D. Brain Research, 1995, 702, 266.
174. Leker, R.R.; Shohami, E.; Abramsky, O.; Ovadia, H. Journal of the Neurological Sciences, 1999, 162, 114.
175. Van Der Stelt, M.; Veldhuis, W.B.; Van Haaften, G.W.; Fezza, F.; Bisogno, T.; Bar, P.R.; Veldink, G.A.; Vliegenthart, J.F.; Di Marzo, V.; Nicolay, K. Journal of Neuroscience, 2001, 21, 8765.
176. Baker, D.; Pryce, G.; Croxford, J.L.; Brown, P.; Pertwee, R.G.; Makriyannis, A.; Khanolkar, A.; Layward, L.; Fezza, F.; Bisogno, T.; Di Marzo, V. FASEB Journal, 2001, 15, 300.
177. Lastres-Becker, I.; Berrendero, F.; Lucas, J.J.; Martin-Aparicio, E.; Yamamoto, A.; Ramos, J.A.; Fernandez-Ruiz, J.J. Brain Research, 2002, 929, 236.
178. Noyes, R.; Brunk, S.F.; Baram, D.A.; Baram, A. Journal of Clinical Pharmacology, 1975, 15, 139.
179. Indevus Pharmaceuticals, 2002, http://www.interneuron.com
180. Trembly, B.; Sherman, M., 1990. Cited in Musty, R.E. Biology of Marijuana: From Gene to Behavior; Onaivi, Ed.; Taylor & Francis: London, 2002, pp. 45-74.
181. Petro, D.J.; Ellenberger, C. Journal of Clinical Pharmacology, 1981, 21, 413S.
182. Huggett, 2001, http://www.bioworld.com/servlet/com.accumedia.web. Dispatcher?next=bio WorldToday
183. Warner, R.; Taylor, D.; Wright, J.; Sloat, A.; Springett, G.; Arnold, S.; Weinberg, H. American Journal of Orthopsychiatry, 1994, 64, 30.
184. Patton, G.C.; Coffey, C.; Carlin, J.B.; Degenhardt, L.; Lynskey, M.; Hall, W. British Medical Journal, 2002, 325, 1195.
185. Arseneault, L.; Cannon, M.; Poulton, R.; Murray; R.; Caspi; A.; Moffitt; T.E. British Medical Journal, 2002, 325, 1212.
186. Van Os, J.; Bak, M.; Hanssen, M.; Bijl, R.V.; De Graaf, R.; Verdoux, H. American Journal of Epidemiology, 2002, 156, 319.
187. Peralta, V.; Cuesta, M.J. Acta Psychiatrica Scandinavica, 1992, 85, 127.